Literature DB >> 11313957

Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid.

M Gatei1, D Shkedy, K K Khanna, T Uziel, Y Shiloh, T K Pandita, M F Lavin, G Rotman.   

Abstract

Cells from patients with the genetic disorder ataxia-telangiectasia (A-T) are hypersensitive to ionizing radiation and radiomimetic agents, both of which generate reactive oxygen species capable of causing oxidative damage to DNA and other macromolecules. We describe in A-T cells constitutive activation of pathways that normally respond to genotoxic stress. Basal levels of p53 and p21(WAF1/CIP1), phosphorylation on serine 15 of p53, and the Tyr15-phosphorylated form of cdc2 are chronically elevated in these cells. Treatment of A-T cells with the antioxidant alpha-lipoic acid significantly reduced the levels of these proteins, pointing to the involvement of reactive oxygen species in their chronic activation. These findings suggest that the absence of functional ATM results in a mild but continuous state of oxidative stress, which could account for several features of the pleiotropic phenotype of A-T.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313957     DOI: 10.1038/sj.onc.1204111

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

Authors:  Narasimharao Nalabothula; Devulapalli Chakravarty; Adam Pierce; France Carrier
Journal:  Mol Cell Pharmacol       Date:  2010

3.  All stressed out without ATM kinase.

Authors:  J Jefferson P Perry; John A Tainer
Journal:  Sci Signal       Date:  2011-04-05       Impact factor: 8.192

4.  Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice.

Authors:  Philip Chen; Cheng Peng; John Luff; Kevin Spring; Dianne Watters; Steven Bottle; Shigeki Furuya; Martin F Lavin
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

5.  Requirement of the MRN complex for ATM activation by DNA damage.

Authors:  Tamar Uziel; Yaniv Lerenthal; Lilach Moyal; Yair Andegeko; Leonid Mittelman; Yosef Shiloh
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 6.  Oxidative stress as a cofactor in spinocerebellar ataxia type 2.

Authors:  Mariela Guevara-García; Lizette Gil-del Valle; Luis Velásquez-Pérez; Julio César García-Rodríguez
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

7.  Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis.

Authors:  Heather L Armata; Diane Golebiowski; Dae Young Jung; Hwi Jin Ko; Jason K Kim; Hayla K Sluss
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

8.  45S rDNA regions are chromosome fragile sites expressed as gaps in vitro on metaphase chromosomes of root-tip meristematic cells in Lolium spp.

Authors:  Jing Huang; Lu Ma; Fei Yang; Shui-zhang Fei; Lijia Li
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

9.  The Aspergillus nidulans ATM kinase regulates mitochondrial function, glucose uptake and the carbon starvation response.

Authors:  Nadia Graciele Krohn; Neil Andrew Brown; Ana Cristina Colabardini; Thaila Reis; Marcela Savoldi; Taísa Magnani Dinamarco; Maria Helena S Goldman; Gustavo Henrique Goldman
Journal:  G3 (Bethesda)       Date:  2014-01-10       Impact factor: 3.154

Review 10.  Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis?

Authors:  Majid Zaki-Dizaji; Seyed Mohammad Akrami; Gholamreza Azizi; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Inflamm Res       Date:  2018-03-26       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.